Janik Puttemans
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- CAR-T cell therapy research
- HER2/EGFR in Cancer Research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 12
- Radiopharmaceutical Chemistry and Applications 8
- Oncology 9
- CAR-T cell therapy research 3
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 2
- Co-authors
- Nick Devoogdt (13 shared papers)Tony Lahoutte (7 shared papers)Matthias D’Huyvetter (7 shared papers)Marleen Keyaerts (5 shared papers)Yana Dekempeneer (4 shared papers)Serge Muyldermans (3 shared papers)Ahmet Krasniqi (3 shared papers)Karine Breckpot (8 shared papers)
- Journals
- Frontiers in Immunology (2 papers)Molecular Pharmaceutics (1 paper)Pharmaceutics (1 paper)International Journal of Molecular Sciences (1 paper)Advanced Science (1 paper)
- Partner nations
- BelgiumNetherlandsGermany
In The Last Decade
Janik Puttemans
16 papers receiving 499 citations
Peers
Comparison fields: 5 of 50
- Radiology, Nuclear Medicine and Imaging 340
- Oncology 157
- Immunology 111
- Radiation 28
- Pulmonary and Respiratory Medicine 95
Countries citing papers authored by Janik Puttemans
This map shows the geographic impact of Janik Puttemans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janik Puttemans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janik Puttemans more than expected).
Fields of papers citing papers by Janik Puttemans
This network shows the impact of papers produced by Janik Puttemans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janik Puttemans. The network helps show where Janik Puttemans may publish in the future.
Co-authors
The 25 scholars most cited alongside Janik Puttemans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 126 | |
| 2 | 2016 | 89 | |
| 3 | 2020 | 55 | |
| 4 | 2019 | 48 | |
| 5 | 2017 | 44 | |
| 6 | 2021 | 26 | |
| 7 | 2023 | 21 | |
| 8 | The road to personalized myeloma medicine | 2022 | 20 |
| 9 | 2019 | 20 | |
| 10 | 2021 | 18 | |
| 11 | 2021 | 10 | |
| 12 | 2021 | 9 | |
| 13 | 2024 | 6 | |
| 14 | 2021 | 5 | |
| 15 | 2019 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 0 |
About Janik Puttemans
Janik Puttemans is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Biomaterials and Immunology, having authored 17 papers that have together received 504 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Radiopharmaceutical Chemistry and Applications (8 papers), CAR-T cell therapy research (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Nanoplatforms for cancer theranostics (2 papers), Immunotherapy and Immune Responses (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (340 citations), Oncology (157 citations), Immunology (111 citations), Radiation (28 citations) and Pulmonary and Respiratory Medicine (95 citations). Janik Puttemans has collaborated with scholars based in Belgium, Netherlands and Germany. Frequent co-authors include Nick Devoogdt, Tony Lahoutte, Matthias D’Huyvetter, Marleen Keyaerts, Yana Dekempeneer, Serge Muyldermans, Ahmet Krasniqi, Karine Breckpot, Pieterjan Debie and Cleo Goyvaerts. Their work appears in journals such as Frontiers in Immunology, Molecular Pharmaceutics, Pharmaceutics, International Journal of Molecular Sciences and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.